Takara Bio Europe has introduced Cellartis® MSC EV Wonder™, a chemically defined, xeno-free culture medium designed to address scalability challenges in mesenchymal stem cell-derived extracellular vesicle (MSC-EV) manufacturing. The product targets researchers developing cell-free therapeutic candidates for regenerative medicine and immunomodulation applications.
SynGenSys has introduced NK.SET™, the first commercially available synthetic promoter library designed specifically for natural killer (NK) cell immunotherapies. The Sheffield-based biotechnology company’s announce-ment marks a significant validation of its platform for engineering tissue-specific gene regulation control elements.
Bio-Rad launches consolidated specialty immunoassay quality control in Europe Bio-Rad Laboratories has introduced its Specialty Immunoassay Plus (SPIA Plus) control system to European clinical laboratories, offering enhanced quality monitoring capabilities for specialty immunoassay testing procedures.
Amsbio has launched an expanded portfolio of ready-to-use, sterile cell lines designed to accelerate CAR-T cell therapy research for leukaemia treatment. The offering addresses growing demand for standardised cellular tools following the 2017 FDA approval of CAR-T therapy for children and adolescents with B cell acute lymphoblastic leukaemia (ALL).
Thermo Fisher Scientific has introduced Invitrogen UltraComp eBeads Spectral Unmixing Beads, a next-generation com-pensation tool designed to improve signal accuracy in spectral and conventional flow cytometry applications. The product addresses persistent challenges in fluoro-chrome separation and background inter-ference that can compromise data quality in multi-parameter cellular analysis.
Nilo Therapeutics has launched with $101 million in Series A financing to develop therapies that target the brain’s control of immune responses, marking a significant departure from conventional approaches to autoimmune and inflammatory disease treatment. The funding round, led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and […]
Advanced Chemistry Development (ACD/Labs) and materials science company Covestro have unveiled a collaborative project integrating artificial intelligence into solvent selection processes for pharmaceutical and chemical research. The partnership, announced at the PhysChem Forum 2025 in Basel, Switzerland, combines computational chemistry expertise with software development to address long-standing inefficiencies in laboratory workflows.
Researchers at the University of Connecticut have developed CARRD, a novel RNA detection method that operates at room temperature without pre-amplification, achieving attomolar sensitivity for viral diagnostics. The technique detected HIV and hepatitis C virus RNA at concentrations 10,000 times lower than standard CRISPR tests, potentially transforming point-of-care diagnostics in resource-limited settings.
Open-science publisher Frontiers has launched FAIR² Data Management, an integrated platform designed to address the significant challenge of scientific data loss and underutilisation. The service combines artificial intelligence with established data management protocols to streamline how research data is stored, shared, and reused across scientific disciplines.
Scientists at the University of Cambridge have created three-dimensional embryo-like structures from human stem cells that spontaneously produce blood cells, offering a new window into early human development and a potential source of cells for transplantation. The structures, called ‘hematoids’, develop beating heart cells and blood stem cells without requiring the complex cocktails of growth […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.